Skip to main content
Quest Diagnostics Home

Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk

Date: Wednesday, May 27, 2020

Description: In these unprecedented times, patients, especially the elderly and those with a history of coronary artery disease, are at particular risk of adverse outcomes with COVID-19. There has been long-term recognition that viral infections may lead to an increase in risk for myocardial infarction (MI).

This will be a discussion focusing on:

  • The role that viral infections play in vascular inflammation and plaque rupture 
  • How to identify those patients at increased risk for a cardiovascular event with viral respiratory infection 
  • Tools to monitor therapeutic response

Author:

Penn, Marc S., MD
Co-Founder and Chief Medical Officer, Cleveland HeartLab, Quest Diagnostics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.